Position in ABOS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$31,062
+$7,099 QoQ
Shares Held
13,162
-6.1% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 84 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $416,725,359 across 197 Biotechnology names. ABOS ranks #168 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,633 | $42,560,800 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
3,925,446 | $30,108,170 | |
| 3 | EXEL |
Exelixis, Inc.
|
460,585 | $19,754,490 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
252,250 | $18,941,452 | |
| 5 | MRNA |
Moderna, Inc.
|
368,421 | $18,715,786 | |
| 6 | ARGX |
Argenx SE
|
18,754 | $13,695,108 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
613,229 | $12,847,147 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
3,486,299 | $12,236,909 |
All Filings in ABOS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,062 | 13,162 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $23,963 | 14,014 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $36,455 | 31,427 | Shares | Defined | 2025-08-14 | |
| 2024-03-31 | $425,723 | 105,117 | Shares | Defined | 2024-05-13 | |
| 2023-03-31 | $175,046 | 43,115 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $111,628 | 20,672 | Shares | Defined | 2023-02-10 | |
| 2021-12-31 | $553,758 | 81,917 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||